Pfizer Inc. (BVMF:PFIZ34)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of BRL 778.96 billion. The enterprise value is 1.03 trillion.

Market Cap	778.96B
Enterprise Value	1.03T

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Nov 6, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	65.92%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.83 and the forward PE ratio is 8.36.

PE Ratio	14.83
Forward PE	8.36
PS Ratio	2.32
PB Ratio	1.57
P/TBV Ratio	n/a
P/FCF Ratio	14.05
P/OCF Ratio	11.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.58, with an EV/FCF ratio of 18.57.

EV / Earnings	19.60
EV / Sales	3.10
EV / EBITDA	7.58
EV / EBIT	10.93
EV / FCF	18.57

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	4.14M
Profits Per Employee	648,253
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-3.66B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.10% in the last 52 weeks. The beta is 0.43, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-13.10%
50-Day Moving Average	33.13
200-Day Moving Average	34.20
Relative Strength Index (RSI)	53.64
Average Volume (20 Days)	12,690

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.05

Income Statement

In the last 12 months, Pfizer had revenue of BRL 335.41 billion and earned 52.51 billion in profits. Earnings per share was 9.22.

Revenue	335.41B
Gross Profit	250.91B
Operating Income	94.97B
Pretax Income	48.90B
Net Income	52.51B
EBITDA	130.66B
EBIT	94.97B
Earnings Per Share (EPS)	9.22

Balance Sheet

The company has 80.05 billion in cash and 330.89 billion in debt, giving a net cash position of -250.84 billion.

Cash & Cash Equivalents	80.05B
Total Debt	330.89B
Net Cash	-250.84B
Net Cash Per Share	n/a
Equity (Book Value)	497.34B
Book Value Per Share	87.19
Working Capital	55.17B

Cash Flow

In the last 12 months, operating cash flow was 69.86 billion and capital expenditures -14.43 billion, giving a free cash flow of 55.43 billion.

Operating Cash Flow	69.86B
Capital Expenditures	-14.43B
Free Cash Flow	55.43B
FCF Per Share	n/a

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 1.61, which amounts to a dividend yield of 4.71%.

Dividend Per Share	1.61
Dividend Yield	4.71%
Dividend Growth (YoY)	2.57%
Years of Dividend Growth	1
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	4.52%
Earnings Yield	6.74%
FCF Yield	7.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 4.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	4

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7